X0508 4 2026-02-22 0 0001706431 Vir Biotechnology, Inc. VIR 0002037272 Sabatini Brent C/O VIR BIOTECHNOLOGY, INC. 1800 OWENS STREET, SUITE 900 SAN FRANCISCO CA 94158 0 1 0 0 SVP, Chief Accounting Officer 1 Common Stock 2026-02-22 4 A 0 25000 0 A 72872 D Common Stock 2026-02-23 4 S 0 1829 7.4528 D 71043 D Stock Option (Right to Buy) 7.56 2026-02-22 4 A 0 50000 0 A 2036-02-21 Common Stock 50000 50000 D Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.v 25% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter. /s/ Vanina de Verneuil, Attorney-In-Fact 2026-02-24